Back to Insider Trading View Full Company Profile

GENB

Generate Biomedicines, Inc.

CIK: 0002100782

Strong Buy (90% confidence)

Last activity: Mar 4, 2026

Trend Signals

CEO Buy STRONG

CEO buying activity

Mar 4, 2026

CFO Buy STRONG

CFO buying activity

Mar 2, 2026

Insider Roster (5 total, 5 active)

Insider Buys Sells Net Value Holdings
AFEYAN NOUBAR
OTHER
6 0 $150.00M
15,264,724 shares
$244.24M
Nally Michael
Chief Executive Officer
1 0 $240K
572,707 shares
$6.87M
Silvers Jason
President & CFO
3 0 $32K
1,000 shares
$16K
Mendillo Jane L
OTHER
1 0 $24K
1,500 shares
$24K
Grous Beth
Chief People Officer
1 0 $5K
300 shares
$5K

Recent Transactions

BUY Nally Michael (Chief Executive Officer)

20,000 shares @ $12.00

$240K

Mar 4, 2026

Conviction: | View SEC Filing →
BUY AFEYAN NOUBAR (OTHER)

1,562,500 shares @ $16.00

$25.00M

Mar 2, 2026

Conviction: | View SEC Filing →
BUY AFEYAN NOUBAR (OTHER)

1,562,500 shares @ $16.00

$25.00M

Mar 2, 2026

Conviction: | View SEC Filing →
BUY AFEYAN NOUBAR (OTHER)

1,562,500 shares @ $16.00

$25.00M

Mar 2, 2026

Conviction: | View SEC Filing →
BUY AFEYAN NOUBAR (OTHER)

1,562,500 shares @ $16.00

$25.00M

Mar 2, 2026

Conviction: | View SEC Filing →
BUY AFEYAN NOUBAR (OTHER)

1,562,500 shares @ $16.00

$25.00M

Mar 2, 2026

Conviction: | View SEC Filing →
BUY AFEYAN NOUBAR (OTHER)

1,562,500 shares @ $16.00

$25.00M

Mar 2, 2026

Conviction: | View SEC Filing →
BUY Mendillo Jane L (OTHER)

1,500 shares @ $16.00

$24K

Mar 2, 2026

Conviction: | View SEC Filing →
BUY Silvers Jason (President & CFO)

1,000 shares @ $16.00

$16K

Mar 2, 2026

Conviction: | View SEC Filing →
BUY Silvers Jason (President & CFO)

500 shares @ $16.00

$8K

Mar 2, 2026

Conviction: | View SEC Filing →
BUY Silvers Jason (President & CFO)

500 shares @ $16.00

$8K

Mar 2, 2026

Conviction: | View SEC Filing →
BUY Grous Beth (Chief People Officer)

300 shares @ $16.00

$5K

Mar 2, 2026

Conviction: | View SEC Filing →

⚠️ Important Disclaimer

• This is AI-generated analysis for educational purposes only, not financial advice.

• Insider trading data is derived from SEC Form 4 filings and may contain errors.

• Always conduct your own research and consult qualified financial advisors before making investment decisions.